5 Key Takeaways

• 1

  A randomized clinical trial found that nicotine replacement therapy with behavioral support reduced cigarette consumption in opioid users.

• 2

  The trial involved 259 participants from seven opioid agonist therapy clinics in Norway, with a mean age of 48.5 years.

• 3

  At week 16, 29.6% of the intervention group reduced daily cigarette consumption by half compared to 16.9% in the control group.

• 4

  A per-protocol analysis showed 45.1% of the intervention group reduced smoking versus 20.4% in the control group.

• 5

  The study's design included all eligible participants, regardless of their motivation to change smoking habits.